Contraindications for Injection Enoxaparin
Enoxaparin is absolutely contraindicated in patients with active major bleeding, thrombocytopenia with positive antiplatelet antibodies in the presence of enoxaparin, and known hypersensitivity to enoxaparin, heparin, or pork products. 1
Absolute Contraindications
Based on FDA labeling and clinical guidelines, enoxaparin should NOT be used in the following situations:
1. Active Major Bleeding
- Any active bleeding at any site, tissue, or organ 2, 1
- This is a hard stop—do not initiate enoxaparin if the patient is actively bleeding
2. Thrombocytopenia-Related
- Thrombocytopenia with a positive in vitro test for antiplatelet antibody in the presence of enoxaparin 2, 1
- History of heparin-induced thrombocytopenia (HIT) 2
- This represents an immune-mediated reaction that can cause catastrophic thrombosis
3. Hypersensitivity Reactions
- Known hypersensitivity to enoxaparin sodium (including pruritus, urticaria, anaphylactic/anaphylactoid reactions) 1
- Known hypersensitivity to heparin or pork products 2, 1
- Known hypersensitivity to benzyl alcohol (applies only to the multi-dose formulation) 1
4. Severe Renal Impairment
- Creatinine clearance <30 mL/min is a contraindication in some contexts 3, 4, 5
- Fondaparinux is contraindicated at CrCl <30 mL/min, and enoxaparin requires either dose adjustment (1 mg/kg SC once daily instead of twice daily) or should be avoided entirely 2, 6, 5
- The European guidelines state enoxaparin is contraindicated in severe renal failure (<30 mL/min) 3, 4
Critical Precautions (Use with Extreme Caution)
While not absolute contraindications, the following situations require extreme caution and may warrant alternative anticoagulation:
- Uncontrolled arterial hypertension (systolic ≥200 mmHg, diastolic ≥110 mmHg) 2
- Liver failure with elevated INR >1.5 2
- Severe thrombocytopenia (any degree requires active monitoring) 2
- Conditions with increased hemorrhage risk: bacterial endocarditis, congenital/acquired bleeding disorders, active ulcerative gastrointestinal disease, diabetic retinopathy, recent brain/spinal/ophthalmologic surgery 2
Common Pitfalls to Avoid
Do not switch between enoxaparin and UFH or other LMWHs—this increases bleeding risk significantly 7, 6
Renal dosing is critical: In patients with CrCl 30-60 mL/min, reduce dose to 75% of recommended full dose; at CrCl <30 mL/min, either avoid or use 1 mg/kg once daily 3, 8, 6
Age considerations: In patients ≥75 years receiving enoxaparin for STEMI, omit the IV bolus and use 0.75 mg/kg SC every 12 hours 7, 6
Neuraxial anesthesia warning: Epidural or spinal hematomas can occur in anticoagulated patients receiving neuraxial anesthesia—this can result in permanent paralysis 1
Mechanical prosthetic heart valves: Enoxaparin is not adequately studied in pregnant women with mechanical heart valves and may pose increased risk 1